T. Rowe Price Associates’s 1Life Healthcare ONEM Stock Holding History

T. Rowe Price Associates’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-76,222	Closed	-$1.27M	–	2991
2022 Q4	$1.27M	Sell	76,222 -2,184	-3%	-$36.9K	﹤0.01%	1651
2022 Q3	$1.34M	Sell	78,406 -87,375	-53%	-$1.37M	﹤0.01%	1610
2022 Q2	$1.3M	Buy	165,781 +26,963	+19%	+$232K	﹤0.01%	1771
2022 Q1	$1.54M	Sell	138,818 -232,093	-63%	-$2.6M	﹤0.01%	1806
2021 Q4	$6.52M	Buy	370,911 +265,233	+251%	+$5.14M	﹤0.01%	1470
2021 Q3	$2.14M	Buy	105,678 +67,469	+177%	+$1.73M	﹤0.01%	1699
2021 Q2	$1.26M	Buy	38,209 +5,937	+18%	+$224K	﹤0.01%	1964
2021 Q1	$1.26M	Buy	32,272 +497	+2%	+$23.3K	﹤0.01%	1937
2020 Q4	$1.39M	Sell	31,775 -558,245	-95%	-$19.1M	﹤0.01%	1792
2020 Q3	$16.7M	Buy	+590,020	New	+$18.6M	﹤0.01%	1195

T. Rowe Price Associates's ONEM Position: Q1 2023 in Review

T. Rowe Price Associates sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 76,222 shares — an estimated $1.27M sold.

T. Rowe Price Associates first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $16.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

T. Rowe Price Associates reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
T. Rowe Price Associates sold 76,222 1Life Healthcare shares in Q1 2023, an estimated $1.27M.
T. Rowe Price Associates first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
T. Rowe Price Associates's 1Life Healthcare position peaked at $16.7M in Q3 2020.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.